Metalloporphyrins as a therapeutic drug class against peroxynitrite in cardiovascular diseases involving ischemic reperfusion injury

European Journal of Pharmacology

Volumn 586, Issue 1-3, 2008, Pages 1-8

  Rabkin, Simon W ^a   Klassen, Shaun S ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Heart; Ischemic reperfusion injury; Metalloporphyrin; Peroxynitrite; Scavenger decomposition catalyst; Stroke

Indexed keywords

5,10,15,20 TETRAKIS(2,4,6 TRIMETHYL 3,3 DISULFONATOPHENYL)PORPHYRINATO IRON; 5,10,15,20 TETRAKIS(4 SULFONATOPHENYL)PORPHYRINATO IRON; 5,10,15,20 TETRAKIS(BENZOIC ACID)PORPHYRINATO IRON; 5,10,15,20 TETRAKIS(BENZOIC ACID)PORPHYRINATO MANGANESE; 5,10,15,20 TETRAKIS(N METHYL 4' PYRIDYL)PORPHYRINATO IRON; 5,10,15,20 TETRAKIS(N METHYL 4' PYRIDYL)PORPHYRINATO MANGANESE; HIGH DENSITY LIPOPROTEIN; IRON CHLORIDE 5,10,15,20 TETRAKIS 2 (N TRIETHYLENE GLYCOLMONOMETHYL ETHER)PYRIDYLPORPHYRIN; IRON PROTOPORPHYRIN IX; METALLOPORPHYRIN; PEROXYNITRITE; PROTOPORPHYRIN IX MANGANESE; WW 85;

ACUTE HEART INFARCTION; ATHEROSCLEROTIC CARDIOVASCULAR DISEASE; BLOOD VESSEL REACTIVITY; BRAIN INFARCTION SIZE; CARDIOMYOPATHY; CARDIOTOXICITY; CARDIOVASCULAR DISEASE; CATALYST; CEREBROVASCULAR ACCIDENT; CONGESTIVE CARDIOMYOPATHY; DECOMPOSITION; DNA STRAND BREAKAGE; DOSE RESPONSE; DRUG EFFECT; ENDOTHELIAL DYSFUNCTION; GENE MUTATION; HEART FAILURE; HEART INFARCTION; HEART PROTECTION; HEART VENTRICLE HYPERTROPHY; HUMAN; ISCHEMIC HEART DISEASE; LIPID PEROXIDATION; MIDDLE CEREBRAL ARTERY OCCLUSION; NEUROLOGIC DISEASE; NONHUMAN; PRIORITY JOURNAL; REPERFUSION INJURY; REVIEW; SEPTIC SHOCK; STROKE; STRUCTURE ACTIVITY RELATION; TREATMENT OUTCOME;

ANIMALS; CARDIOVASCULAR DISEASES; CATALYSIS; FREE RADICAL SCAVENGERS; HUMANS; METALLOPORPHYRINS; MYOCARDIAL REPERFUSION INJURY; PEROXYNITROUS ACID;

EID: 43549106548     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2008.02.078     Document Type: Review

References (87)

1. Adachi T., Weisbrod R.M., Pimentel D.R., Ying J., Sharov V.S., Schoneich C., and Cohen R.A. S-Glutathiolation by peroxynitrite activates SERCA during arterial relaxation by nitric oxide. Nat. Med. 10 (2004) 1200-1207
2. Akiyama K., Kimura A., Suzuki H., Takeyama Y., Gluckman T.L., Terhakopian A., Katagiri T., Suh K.Y., Roseto J., and Bing R.J. Production of oxidative products of nitric oxide in infarcted human heart. J. Am. Coll. Cardiol. 32 (1998) 373-379
3. Amin J.K., Xiao L., Pimental D.R., Pagano P.J., Singh K., Sawyer D.B., and Colucci W.S. Reactive oxygen species mediate alpha-adrenergic receptor-stimulated hypertrophy in adult rat ventricular myocytes. J. Mol. Cell. Cardiol. 33 (2001) 131-139
4. Arstall M.A., Sawyer D.B., Fukazawa R., and Kelly R.A. Cytokine-mediated apoptosis in cardiac myocytes: the role of inducible nitric oxide synthase induction and peroxynitrite generation. Circ. Res. 85 (1999) 829-840
5. Bianchi C., Wakiyama H., Faro R., Khan T., McCully J.D., Levitsky S., Szabo C., and Sellke F.W. A novel peroxynitrite decomposer catalyst (FP-15) reduces myocardial infarct size in an in vivo peroxynitrite decomposer and acute ischemia-reperfusion in pigs. Ann. Thoracic Surg. 74 (2002) 1201-1207
6. Burney S., Caulfield J.L., Niles J.C., Wishnok J.S., Tannenbaum S.R., Burney S., Caulfield J.L., Niles J.C., Wishnok J.S., and Tannenbaum S.R. The chemistry of DNA damage from nitric oxide and peroxynitrite. Mutation Res. 424 (1999) 37-49
7. Buttery L.D., Springall D.R., Chester A.H., Evans T.J., Standfield E.N., Parums D.V., Yacoub M.H., and Polak J.M. Inducible nitric oxide synthase is present within human atherosclerotic lesions and promotes the formation and activity of peroxynitrite. Lab. Invest. 75 (1996) 77-85
8. Cai L., Wang J., Li Y., Sun X., Wang L., Zhou Z., and Kang Y.J. Inhibition of superoxide generation and associated nitrosative damage is involved in metallothionein prevention of diabetic cardiomyopathy. Diabetes 54 (2005) 1829-1837
9. Chung H.T., Pae H.O., Choi B.M., Billiar T.R., and Kim Y.M. Nitric oxide as a bioregulator of apoptosis. Biochem. Biophys. Res. Comm. 282 (2001) 1075-1079
10. Crow J.P. Manganese and iron porphyrins catalyze peroxynitrite decomposition and simultaneously increase nitration and oxidant yield: implications for their use as peroxynitrite scavengers in vivo. Arch. Biochem. Biophys. 371 (1999) 41-52
11. Crow J.P. Peroxynitrite scavenging by metalloporphyrins and thiolates. Free Radic. Biol. Med. 28 (2000) 1487-1494
12. Cuzzocrea S., Misko T.P., Costantino G., Mazzon E., Micali A., Caputi A.P., Macarthur H., and Salvemini D. Beneficial effects of peroxynitrite decomposition catalyst in a rat model of splanchnic artery occlusion and reperfusion. FASEB J. 14 (2000) 1061-1072
13. Cuzzocrea S., Mazzon E., Di Paola R., Esposito E., Macarthur H., Matuschak G.M., and Salvemini D. A role for nitric oxide-mediated peroxynitrite formation in a model of endotoxin-induced shock. J. Pharmacol. Exp.Therap. 319 (2006) 73-81
14. Daiber A., Oelze M., Coldewey M., Kaiser K., Huth C., Schildknecht S., Bachschmid M., Nazirisadeh Y., Ullrich V., Mulsch A., Munzel T., and Tsilimingas N. Hydralazine is a powerful inhibitor of peroxynitrite formation as a possible explanation for its beneficial effects on prognosis in patients with congestive heart failure. Biochem. Biophys. Res. Comm. 338 (2005) 1865-1874
15. Dhar A., Kaundal R.K., and Sharma S.S. Neuroprotective effects of FeTMPyP: a peroxynitrite decomposition catalyst in global cerebral ischemia model in gerbils. Pharmacol. Res. 54 (2006) 311-316
16. Dickhout J.G., Hossain G.S., Pozza L.M., Zhou J., Lhotak S., and Austin R.C. Peroxynitrite causes endoplasmic reticulum stress and apoptosis in human vascular endothelium: implications in atherogenesis. Arterioscler. Thromb. Vasc. Biol. 25 (2005) 2623-2629
17. Evgenov O.V., and Liaudet L. Role of nitrosative stress and activation of poly(ADP-ribose) polymerase-1 in cardiovascular failure associated with septic and hemorrhagic shock. Current Vasc. Pharmacol. 3 (2005) 293-299
18. Feng Q., Lu X., Jones D.L., Shen J., and Arnold J.M. Increased inducible nitric oxide synthase expression contributes to myocardial dysfunction and higher mortality after myocardial infarction in mice. Circle 104 (2001) 700-704
19. Ferdinandy P., Danial H., Ambrus I., Rothery R.A., Schulz R., Ferdinandy P., Danial H., Ambrus I., Rothery R.A., and Schulz R. Peroxynitrite is a major contributor to cytokine-induced myocardial contractile failure. Circ. Res. 87 (2000) 241-247
20. Ferretti G., Bacchetti T., Negre-Salvayre A., Salvayre R., Dousset N., and Curatola G. Structural modifications of HDL and functional consequences. Atherosclerosis 184 (2006) 1-7
21. Floris R., Piersma S.R., Yang G., Jones P., and Wever R. Interaction of myeloperoxidase with peroxynitrite. A comparison with lactoperoxidase, horseradish peroxidase and catalase [erratum appears in Eur J Biochem 1993 216:881]. Europ. J. Biochem. 215 (1993) 767-775
22. Forster C., Clark H.B., Ross M.E., and Iadecola C. Inducible nitric oxide synthase expression in human cerebral infarcts. Acta Neuropathologica 97 (1999) 215-220
23. Hayashi Y., Sawa Y., Ohtake S., Fukuyama N., Nakazawa H., and Matsuda H. Peroxynitrite formation from human myocardium after ischemia-reperfusion during open heart operation. Ann. Thoracic Surgery 72 (2001) 571-576
24. Heger J., Godecke A., Flogel U., Merx M.W., Molojavyi A., Kuhn-Velten W.N., and Schrader J. Cardiac-specific overexpression of inducible nitric oxide synthase does not result in severe cardiac dysfunction. Circ.Res. 90 (2002) 93-99
25. Hu A., Jiao X., Gao E., Koch W.J., Sharifi-Azad S., Grunwald Z., Ma X.L., and Sun J.Z. Chronic beta-adrenergic receptor stimulation induces cardiac apoptosis and aggravates myocardial ischemia/reperfusion injury by provoking inducible nitric-oxide synthase-mediated nitrative stress. J. Pharmacol. Exp. Ther. 318 (2006) 469-475
26. Hunt M.J., Aru G.M., Hayden M.R., Moore C.K., Hoit B.D., and Tyagi S.C. Induction of oxidative stress and disintegrin metalloproteinase in human heart end-stage failure. Am. J. Physiol., Lung cell. Mol. Physiol. 283 (2002) L239-L245
27. Ignarro L.J., Fukuto J.M., Griscavage J.M., Rogers N.E., and Byrns R.E. Oxidation of nitric oxide in aqueous solution to nitrite but not nitrate: comparison with enzymatically formed nitric oxide from L-arginine. Proc. Natl. Acad. Sci. (USA) 90 (1993) 8103-8107
28. Katori T., Donzelli S., Tocchetti C.G., Miranda K.M., Cormaci G., Thomas D.D., Ketner E.A., Lee M.J., Mancardi D., Wink D.A., Kass D.A., and Paolocci N. Peroxynitrite and myocardial contractility: in vivo versus in vitro effects. Free Radic. Biol. Med. 41 (2006) 1606-1618
29. Keira N., Tatsumi T., Matoba S., Shiraishi J., Yamanaka S., Akashi K., Kobara M., Asayama J., Fushiki S., Fliss H., and Nakagawa M. Lethal effect of cytokine-induced nitric oxide and peroxynitrite on cultured rat cardiac myocytes. J. Mol. Cell. Cardiol. 34 (2002) 583-596
30. Lancel S., Tissier S., Mordon S., Marechal X., Depontieu F., Scherpereel A., Chopin C., Neviere R., Lancel S., Tissier S., Mordon S., Marechal X., Depontieu F., Scherpereel A., Chopin C., and Neviere R. Peroxynitrite decomposition catalysts prevent myocardial dysfunction and inflammation in endotoxemic rats. J. Am. Coll. Cardiol. 43 (2004) 2348-2358
31. Lee J., Hunt J.A., and Groves J.T. Mechanisms of iron prophyrin reactions with peroxynitrite. J. Am. Chem. Society 120 (1998) 7493-7501
32. Leeuwenburgh C., Hardy M.M., Hazen S.L., Wagner P., Oh-ishi S., Steinbrecher U.P., and Heinecke J.W. Reactive nitrogen intermediates promote low density lipoprotein oxidation in human atherosclerotic intima. J. Biol. Chem. 272 (1997) 1433-1436
33. Levrand S., Vannay-Bouchiche C., Pesse B., Pacher P., Feihl F., Waeber B., and Liaudet L. Peroxynitrite is a major trigger of cardiomyocyte apoptosis in vitro and in vivo. Free Radic. Biol. Med. 41 (2006) 886-895
34. Li X., De Sarno P., Song L., Beckman J.S., Jope R.S., Li X., De Sarno P., Song L., Beckman J.S., and Jope R.S. Peroxynitrite modulates tyrosine phosphorylation and phosphoinositide signalling in human neuroblastoma SH-SY5Y cells: attenuated effects in human 1321N1 astrocytoma cells. Biochem. J. 331 (1998) 599-606
35. 2+-ATPase in human heart failure. Circ. 111 (2005) 988-995
36. Luoma J.S., Stralin P., Marklund S.L., Hiltunen T.P., Sarkioja T., and Yla-Herttuala S. Expression of extracellular SOD and iNOS in macrophages and smooth muscle cells in human and rabbit atherosclerotic lesions: colocalization with epitopes characteristic of oxidized LDL and peroxynitrite-modified proteins. Arterioscler. Thromb. Vasc. Biol. 18 (1998) 157-167
37. Marfella R., Esposito K., Nappo F., Siniscalchi M., Sasso F.C., Portoghese M., Di Marino M.P., Baldi A., Cuzzocrea S., Di Filippo C., Barboso G., Baldi F., Rossi F., D'Amico M., and Giugliano D. Expression of angiogenic factors during acute coronary syndromes in human type 2 diabetes. Diabetes 53 (2004) 2383-2391
38. Mihm M.J., Coyle C.M., Schanbacher B.L., Weinstein D.M., and Bauer J.A. Peroxynitrite induced nitration and inactivation of myofibrillar creatine kinase in experimental heart failure. Cardiovasc. Res. 49 (2001) 798-807
39. Misko T.P., Highkin M.K., Veenhuizen A.W., Manning P.T., Stern M.K., Currie M.G., and Salvemini D. Characterization of the cytoprotective action of peroxynitrite decomposition catalysts. J. Biol. Chem. 273 (1998) 15646-15653
40. Morton L.W., Puddey I.B., and Croft K.D. Comparison of nitration and oxidation of tyrosine in advanced human carotid plaque proteins. Biochemical J. 370 (2003) 339-344
41. Moss G.P., Smith P.A.S., and Tavernier D. Glossary of class names of organic compounds and reactive intermediates based on structure. Pure Appl. Chem. 67 (1995) 1307-1375
42. Mungrue I.N., Gros R., You X., Pirani A., Azad A., Csont T., Schulz R., Butany J., Stewart D.J., and Husain M. Cardiomyocyte overexpression of iNOS in mice results in peroxynitrite generation, heart block, and sudden death. J. Clin. Invest. 109 (2002) 735-743
43. Nanetti L., Taffi R., Vignini A., Moroni C., Raffaelli F., Bacchetti T., Silvestrini M., Provinciali L., and Mazzanti L. Reactive oxygen species plasmatic levels in ischemic stroke. Mol. Cell. Biochem. 303 (2007) 19-25
44. Nangle M.R., Cotter M.A., and Cameron N.E. Effects of the peroxynitrite decomposition catalyst, FeTMPyP, on function of corpus cavernosum from diabetic mice. Eur. J. Pharmacol. 502 (2004) 143-148
45. Nilakantan V., Zhou X., Hilton G., Shi Y., Baker J.E., Khanna A.K., and Pieper G.M. Antagonizing reactive oxygen by treatment with a manganese (III) metalloporphyrin-based superoxide dismutase mimetic in cardiac transplants. J. Thorac. Cardiovas. Surg. 131 (2006) 898-906
46. Nossuli T.O., Hayward R., Scalia R., and Lefer A.M. Peroxynitrite reduces myocardial infarct size and preserves coronary endothelium after ischemia and reperfusion in cats. Circulation 96 (1997) 2317-2324
47. Onody A., Csonka C., Giricz Z., and Ferdinandy P. Hyperlipidemia induced by a cholesterol-rich diet leads to enhanced peroxynitrite formation in rat hearts. Cardiovasc. Res. 58 (2003) 663-670
48. Pacher P., Beckman J.S., and Liaudet L. Nitric oxide and peroxynitrite in health and disease. Physiol. Rev. 87 (2007) 315-424
49. Pacher P., Liaudet L., Bai P., Mabley J.G., Kaminski P.M., Virag L., Deb A., Szabo E., Ungvari Z., Wolin M.S., Groves J.T., and Szabo C. Potent metalloporphyrin peroxynitrite decomposition catalyst protects against the development of doxorubicin-induced cardiac dysfunction. Circulation 107 (2003) 896-904
50. Pennathur S., Bergt C., Shao B., Byun J., Kassim S.Y., Singh P., Green P.S., McDonald T.O., Brunzell J., Chait A., Oram J.F., O'Brien K., Geary R.L., and Heinecke J.W. Human atherosclerotic intima and blood of patients with established coronary artery disease contain high density lipoprotein damaged by reactive nitrogen species. J. Biol. Chem. 279 (2004) 42977-42983
51. Pieper G.M., Nilakantan V., Chen M., Zhou J., Khanna A.K., Henderson Jr. J.D., Johnson C.P., Roza A.M., and Szabo C. Protective mechanisms of a metalloporphyrinic peroxynitrite decomposition catalyst, WW85, in rat cardiac transplants [erratum appears in J Pharmacol. Exp. Ther. 2006 317:462]. J. Pharmacol. Exp. Ther. 314 (2005) 53-60
52. Ponka P., and Ponka P. Cell biology of heme. Am. J. Med. Sci. 318 (1999) 241-256
53. Pryor W.A., Lemercier J.N., Zhang H., Uppu R.M., and Squadrito G.L. The catalytic role of carbon dioxide in the decomposition of peroxynitrite [erratum appears in Free Radic Biol Med 1998;24:508]. Free Radical Biology & Med. 23 (1997) 331-338
54. Quijano C., Alvarez B., Gatti R.M., Augusto O., Radi R., Quijano C., Alvarez B., Gatti R.M., Augusto O., and Radi R. Pathways of peroxynitrite oxidation of thiol groups. Biochem. J. 322 (1997) 167-173
55. Rabkin S.W., and Kong J.Y. Nitroprusside induces cardiomyocyte death: interaction with hydrogen peroxide. Am. J. Physiol.-Heart Circ. Physiol. 279 (2000) H3089-H3100
56. Rabkin S.W., Klassen S.S., and Tsang M.Y. Sodium nitroprusside activates p38 mitogen activated protein kinase through a cGMP/PKG independent mechanism. Life Sci. 81 (2007) 640-646
57. Radi R., Beckman J.S., Bush K.M., and Freeman B.A. Peroxynitrite-induced membrane lipid peroxidation: the cytotoxic potential of superoxide and nitric oxide. Arch. Biochem. Biophys. 288 (1991) 481-487
58. Radovits T., Seres L., Gero D., Lin L.N., Beller C.J., Chen S.H., Zotkina J., Berger I., Groves J.T., Szabo C., and Szabo G. The peroxynitrite decomposition catalyst FP15 improves ageing-associated cardiac and vascular dysfunction. Mech. Ageing Dev. 128 (2007) 173-181
59. Rossi M.A., Celes M.R., Prado C.M., and Saggioro F.P. Myocardial structural changes in long-term human severe sepsis/septic shock may be responsible for cardiac dysfunction. Shock 27 (2007) 10-18
60. Salvemini D., Wang Z.Q., Stern M.K., Currie M.G., and Misko T.P. Peroxynitrite decomposition catalysts: therapeutics for peroxynitrite-mediated pathology. Proc. Natl. Acad. Sci. (USA) 95 (1998) 2659-2663
61. Sam F., Sawyer D.B., Xie Z., Chang D.L., Ngoy S., Brenner D.A., Siwik D.A., Singh K., Apstein C.S., and Colucci W.S. Mice lacking inducible nitric oxide synthase have improved left ventricular contractile function and reduced apoptotic cell death late after myocardial infarction. Circ. Res. 89 (2001) 351-356
62. Sawa T., Ohshima H., Sawa T., and Ohshima H. Nitrative DNA damage in inflammation and its possible role in carcinogenesis. Nitric Oxide 14 (2006) 91-100
63. Schleyer P. Introduction: aromaticity. Chem. Rev. 101 (2001) 1115-1118
64. Sharma S.S., Munusamy S., Thiyagarajan M., and Kaul C.L. Neuroprotective effect of peroxynitrite decomposition catalyst and poly(adenosine diphosphate-ribose) polymerase inhibitor alone and in combination in rats with focal cerebral ischemia. J. Neurosurg. 101 (2004) 669-675
65. Sharma S.S., Dhar A., and Kaundal R.K. FeTPPS protects against global cerebral ischemic-reperfusion injury in gerbils. Pharm. Res. 55 (2007) 335-342
66. Shimanovich R., and Groves J.T. Mechanisms of peroxynitrite decomposition catalyzed by FeTMPS, a bioactive sulfonated iron porphyrin. Arch. Biochem. Biophys. 387 (2001) 307-317
67. Stefanutti G., Pierro A., Smith V.V., Klein N.J., and Eaton S. Peroxynitrite decomposition catalyst FeTMPyP provides partial protection against intestinal ischemia and reperfusion injury in infant rats. Pediatric. Res. 62 (2007) 43-48
68. Stern M.K., Jensen M.P., and Kramer K. Peroxynitrite decomposition catalysts. J. Am. Chem. Soc. 118 (1996) 8735-8736
69. Sucu N., Unlu A., Tamer L., Aytacoglu B., Ercan B., Dikmengil M., and Atik U. 3-Nitrotyrosine in atherosclerotic blood vessels. Clin. Chem. Lab. Med. 41 (2003) 23-25
70. Szabo C., Mabley J.G., Moeller S.M., Shimanovich R., Pacher P., Virag L., Soriano F.G., Van Duzer J.H., Williams W., Salzman A.L., and Groves J.T. Part I: pathogenetic role of peroxynitrite in the development of diabetes and diabetic vascular complications: studies with FP15, a novel potent peroxynitrite decomposition catalyst. Mol. Med. 8 (2002) 571-580
71. Tan K.H., Harrington S., Purcell W.M., and Hurst R.D. Peroxynitrite mediates nitric oxide-induced blood-brain barrier damage. Neurochem. Res. 29 (2004) 579-587
72. Tao L., Jiao X., Gao E., Lau W.B., Yuan Y., Lopez B., Christopher T., RamachandraRao S.P., Williams W., Southan G., Sharma K., Koch W., and Ma X.L. Nitrative inactivation of thioredoxin-1 and its role in postischemic myocardial apoptosis. Circle 114 (2006) 1395-1402
73. Thiyagarajan M., Kaul C.L., and Sharma S.S. Neuroprotective efficacy and therapeutic time window of peroxynitrite decomposition catalysts in focal cerebral ischemia in rats. Brit. J. Pharmacol. 142 (2004) 899-911
74. Torreilles F., Salman-Tabcheh S., Guerin M., and Torreilles J. Neurodegenerative disorders: the role of peroxynitrite. Brain Res. - Brain Res. Rev. 30 (1999) 153-163
75. Tsang M.Y., Cowie S.E., and Rabkin S.W. Palmitate increases nitric oxide synthase activity that is involved in palmitate-induced cell death in cardiomyocytes. Nitric Oxide 10 (2004) 11-19
76. Uppu R.M., Pryor W.A., Uppu R.M., and Pryor W.A. Carbon dioxide catalysis of the reaction of peroxynitrite with ethyl acetoacetate: an example of aliphatic nitration by peroxynitrite. Biochem. Biophys. Res. Comm. 229 (1996) 764-769
77. van der Vliet A., Hoen P.A., Wong P.S., Bast A., and Cross C.E. Formation of S-nitrosothiols via direct nucleophilic nitrosation of thiols by peroxynitrite with elimination of hydrogen peroxide. J. Biol. Chem. 273 (1998) 30255-30262
78. Vanderheyden M., Bartunek J., Knaapen M., Kockx M., De Bruyne B., and Goethals M. Hemodynamic effects of inducible nitric oxide synthase and nitrotyrosine generation in heart failure. J. Heart Lung Transplant. 23 (2004) 723-728
79. Wang X.L., Liu H.R., Tao L., Liang F., Yan L., Zhao R.R., Lopez B.L., Christopher T.A., and Ma X.L. Role of iNOS-derived reactive nitrogen species and resultant nitrative stress in leukocytes-induced cardiomyocyte apoptosis after myocardial ischemia/reperfusion. Apoptosis 12 (2007) 1209-1217
80. White C.R., Brock T.A., Chang L.Y., Crapo J., Briscoe P., Ku D., Bradley W.A., Gianturco S.H., Gore J., Freeman B.A., et al. Superoxide and peroxynitrite in atherosclerosis. Proc. Natl. Acad. Sci. (USA) 91 (1994) 1044-1048
81. Xiao L., Pimentel D.R., Wang J., Singh K., Colucci W.S., and Sawyer D.B. Role of reactive oxygen species and NAD(P)H oxidase in alpha(1)-adrenoceptor signaling in adult rat cardiac myocytes. Am. J. Physiol. - Cell Physiol. 282 (2002) C926-C934
82. Yermilov V., Rubio J., Ohshima H., Yermilov V., Rubio J., and Ohshima H. Formation of 8-nitroguanine in DNA treated with peroxynitrite in vitro and its rapid removal from DNA by depurination. FEBS Lett. 376 (1995) 207-210
83. Yu X.W., Liu M.Y., Kennedy R.H., and Liu S.J. Both cGMP and peroxynitrite mediate chronic interleukin-6-induced negative inotropy in adult rat ventricular myocytes. J. Physiol. 566 (2005) 341-353
84. Zhang H., Squadrito G.L., Pryor W.A., Zhang H., Squadrito G.L., and Pryor W.A. The mechanism of the peroxynitrite-carbon dioxide reaction probed using tyrosine. Nitric Oxide 1 (1997) 301-307
85. Zhang H., Tao L., Jiao X., Gao E., Lopez B.L., Christopher T.A., Koch W., and Ma X.L. Nitrative thioredoxin inactivation as a cause of enhanced myocardial ischemia/reperfusion injury in the aging heart. Free Radic. Biol. Med. 43 (2007) 39-47
86. Zhang P., Xu X., Hu X., van Deel E.D., Zhu G., and Chen Y. Inducible nitric oxide synthase deficiency protects the heart from systolic overload-induced ventricular hypertrophy and congestive heart failure. Circ. Res. 100 (2007) 1089-1098
87. Zingarelli B., Day B.J., Crapo J.D., Salzman A.L., and Szabo C. The potential role of peroxynitrite in the vascular contractile and cellular energetic failure in endotoxic shock. Brit. J. Pharm. 120 (1997) 259-267